NON-SMALL CELL LUNG CANCER STAGE I
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE I explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE I trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test hunts hidden lung cancer cells to stop return
Disease control Recruiting nowThis study is for people with early-stage non-small cell lung cancer. After standard treatment, a blood test checks for leftover cancer DNA, which raises the risk of the cancer coming back. If the test is positive, participants receive the drug durvalumab to try to lower that DNA…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo aims to shield scarred lungs during cancer radiation
Disease control Recruiting nowThis study tests whether adding the drug BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (lung scarring). About 25 participants will receive both t…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC